Hematology Analyzers
APAC · 1 shared keyword
APAC Urinalysis Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
APAC · 2024–2034 · estimates
Market Dashboard
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Estimate 2024
$817.9 Mn
Estimated value
Estimate 2025
$875.2 Mn
19.5% of the global market
Projected 2034
$1.61 Bn 83.8%
Adds $733.8 Mn over 9 forecast years
CAGR 2025–2034
7.0%
Faster than 9% of 173 Medical Devices markets here
Key players
5
- APAC is 19.47% of the global market.
- Among regions, the largest is North America at $1.92 Bn.
- Fastest growing: Africa at 7.6% a year.
- APAC ranks 3rd of 6 by size among regions.
Market size projection
APACSource: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$733.8 Mn total, 2026–2034
Year-by-year market size, 2024–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $817.9 Mn | — | — |
| 2025 (base) | $875.2 Mn | +$57.3 Mn | — |
| 2026 (forecast) | $936.4 Mn | +$61.3 Mn | +7% |
| 2027 (forecast) | $1.00 Bn | +$65.5 Mn | +14.5% |
| 2028 (forecast) | $1.07 Bn | +$70.1 Mn | +22.5% |
| 2029 (forecast) | $1.15 Bn | +$75.0 Mn | +31.1% |
| 2030 (forecast) | $1.23 Bn | +$80.3 Mn | +40.3% |
| 2031 (forecast) | $1.31 Bn | +$85.9 Mn | +50.1% |
| 2032 (forecast) | $1.41 Bn | +$91.9 Mn | +60.6% |
| 2033 (forecast) | $1.50 Bn | +$98.4 Mn | +71.8% |
| 2034 (forecast) | $1.61 Bn | +$105.3 Mn | +83.8% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Same market worldwide
By geography
- Global $4.49 Bn
-
US
$1.91 Bn
- North America $1.92 Bn
- Europe $947.1 Mn
- APAC (this report) $875.2 Mn
-
China
$385.1 Mn
-
Canada
$359.2 Mn
-
Japan
$277.7 Mn
- Latin America $190.5 Mn
- Middle East $161.3 Mn
-
Germany
$151.9 Mn
-
France
$123.0 Mn
-
Brazil
$125.7 Mn
-
Italy
$110.6 Mn
-
UK
$101.5 Mn
-
Ecuador
$92.8 Mn
-
Saudi Arabia
$84.9 Mn
-
Spain
$77.1 Mn
-
Mexico
$77.0 Mn
-
India
$77.2 Mn
- Africa $62.9 Mn
-
Australia
$59.2 Mn
-
Russia
$47.7 Mn
-
New Zealand
$44.6 Mn
-
South Africa
$26.6 Mn
-
UAE
$20.5 Mn
-
Egypt
$12.2 Mn
-
Philippines
$11.2 Mn
-
Malaysia
$8.3 Mn
-
Hong Kong
$7.3 Mn
-
Singapore
$5.7 Mn
-
Thailand
$5.3 Mn
-
Kenya
$2.9 Mn
The APAC Urinalysis Market Analysis Executive Summary
Urinalysis tests urine for infections, kidney problems, diabetes and other conditions using strips, analysers and microscopes.
Key segments of the urinalysis market include product (Test Strips, Analyzers and Consumables) and application (UTI, Kidney Disease and Diabetes).
APAC Urinalysis Market Dynamics
Market Growth Drivers
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the urinalysis market.
Opportunity
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the urinalysis market room to grow, especially in emerging markets.
Market Restraints
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the urinalysis market.
Competitive Landscape for Urinalysis Market in APAC
The urinalysis market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Key Players
Healthcare Policies and Regulatory Landscape for Urinalysis Market in APAC
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how urinalysis products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Urinalysis right now, from free public sources.
Latest research 2,786 papers since 2021 (worldwide)
- Temperature distribution spatial non-uniformity as a complementary infrared thermography metric: age-group differences and exploratory metabolic associations in 409 healthy adults. Journal of thermal biology, 2026
- Association between urine pH on ICU day 1 and 90-day mortality in sepsis: a retrospective cohort study. Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures), 2026
- When one size does not fit all: evaluating urine culture stewardship strategies for high-risk pediatric patients. Journal of clinical microbiology, 2026
- Characteristics of hospitalized children with immunoglobulin A vasculitis: a 7-year retrospective study of 119,217 pediatric inpatients in China. Frontiers in pediatrics, 2026
- Day to Day Variability and Effects of Collection Conditions on Urinary Renin-Angiotensin-Aldosterone System Biomarkers in Vervet Monkeys (Chlorocebus aethiops sabaeus). Journal of medical primatology, 2026
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Urinalysis in context
Questions, answered with public data
- How much research is published on Urinalysis?
- PubMed lists 2,786 papers added since January 2021 that match this market, worldwide.[1]
[1] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Free data on this topic
- Clinical trials: Diagnostics and lab testing
- New research: Diagnostics and lab testing
- FDA approvals and recalls: Diagnostics and lab testing
- NIH research grants: Diagnostics and lab testing
- Clinical trials: Kidney health
- New research: Kidney health
- FDA approvals and recalls: Kidney health
- NIH research grants: Kidney health
From our blog
Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…